share_log

啓明醫療-B:2024年第二次臨時股東大會、2024年第二次H股類別股東會議及2024年第二次非上市外資股類別股東會議之表決結果

VENUS MEDTECH-B: POLL RESULTS OF THE 2024 SECOND EXTRAORDINARY GENERAL MEETING, 2024 SECOND CLASS MEETING OF HOLDERS OF H SHARES AND 2024 SECOND CLASS MEETING OF HOLDERS OF UNLISTED FOREIGN SHARES

HKEX ·  Dec 5, 2024 20:34

Summary by Moomoo AI

2024年12月5日,啓明醫療於杭州舉行了2024年第二次臨時股東大會、H股類別股東會議及非上市外資股類別股東會議。所有提呈的決議案均獲得通過,包括選舉古軍華先生為獨立非執行董事及多項公司章程修訂。這些會議的召開程序符合中國相關法律法規及公司章程的規定,表決結果合法有效。在臨時股東大會上,普通決議案和特別決議案均獲得超過所需票數的支持。特別決議案包括第2.07A條的修訂及其他公司章程的修訂,均獲得超過三分之二的贊成票。H股類別股東會議和非上市外資股類別股東會議的決議案也均獲得通過,顯示出股東對公司治理的支持。此外,因為古軍華先生的任命,董事會現在完全符合香港上市規則的要求,包括獨立非執行董事的最低人數和比例。這些變動將有助於公司未來的合規運營和治理結構的優化。
2024年12月5日,啓明醫療於杭州舉行了2024年第二次臨時股東大會、H股類別股東會議及非上市外資股類別股東會議。所有提呈的決議案均獲得通過,包括選舉古軍華先生為獨立非執行董事及多項公司章程修訂。這些會議的召開程序符合中國相關法律法規及公司章程的規定,表決結果合法有效。在臨時股東大會上,普通決議案和特別決議案均獲得超過所需票數的支持。特別決議案包括第2.07A條的修訂及其他公司章程的修訂,均獲得超過三分之二的贊成票。H股類別股東會議和非上市外資股類別股東會議的決議案也均獲得通過,顯示出股東對公司治理的支持。此外,因為古軍華先生的任命,董事會現在完全符合香港上市規則的要求,包括獨立非執行董事的最低人數和比例。這些變動將有助於公司未來的合規運營和治理結構的優化。
On December 5, 2024, Kai Ming Medical held the Second Extraordinary General Meeting in 2024, the H Class Shareholders' Meeting and the Non-Listed Offshore Class Shareholders' Meeting in Hangzhou. All of the proposed resolutions were approved, including the election of Mr. Guo Jun Wah as an independent non-executive director and amendments to several company articles of association. The procedure for holding these meetings is in accordance with the relevant laws and regulations of China and the articles of association. The results of the votes are legally valid.At the Extraordinary General Meeting, both the Ordinary Resolution and the Special Resolution were supported by more than the required number of votes. The special resolution, including amendments to section 2.07A and other amendments to...Show More
On December 5, 2024, Kai Ming Medical held the Second Extraordinary General Meeting in 2024, the H Class Shareholders' Meeting and the Non-Listed Offshore Class Shareholders' Meeting in Hangzhou. All of the proposed resolutions were approved, including the election of Mr. Guo Jun Wah as an independent non-executive director and amendments to several company articles of association. The procedure for holding these meetings is in accordance with the relevant laws and regulations of China and the articles of association. The results of the votes are legally valid.At the Extraordinary General Meeting, both the Ordinary Resolution and the Special Resolution were supported by more than the required number of votes. The special resolution, including amendments to section 2.07A and other amendments to the articles of association, received more than two-thirds of the votes in favour. The resolutions of the Class H Shareholders Meeting and the Non-Listed Foreign Equity Class Shareholders' Meeting were also passed, demonstrating shareholders' support for corporate governance.In addition, due to the appointment of Mr. Gujun Wah, the Board now fully complies with the requirements of the Hong Kong Listing Rules, including the minimum number and ratio of independent non-executive directors. These changes will help optimize the company's future compliance operations and governance structure.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more